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Purpose: To evaluate the inhibitory effect of chlorogenic acid on laser‐induced choroidal neovascularization (CNV) 
in a rat model. 
Methods: Intraperitoneal injection of chlorogenic acid (10 mg/kg) was inititated one day prior to laser photo-
coagulation and continued for eight days. Eyes were removed 14 days after laser photocoagulation. Fluorescein 
angiography was employed at seven and 14 days to assess the CNV lesions, and histological examination was 
performed. Quantification of CNV size and leakage were performed both in histological sections and fluorescein 
angiography in order to compare the inhibitory effects of chlorogenic acid on CNV with the results of the control.
Results: Histological analysis showed no significant difference in CNV size between the treated and control groups. 
However, CNV leakage on fluorescein angiography had significantly decreased in the chlorogenic acid‐treated 
group at 14 days after laser photocoagulation compared with that of the control group. In addition, CNV size on 
fluorescein angiography had significantly decreased in the treated group at seven and 14 days. 
Conclusions: These results suggest that chlorogenic acid has anti‐angiogenic effects on CNV and may be useful as 
an inhibitor in the treatment or prevention of neovascular age‐related macular degeneration. 
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Angiogenesis, the process by which new blood vessels are 
formed, is tightly regulated by a balance between positive 
and negative factors [1]. Pathologic angiogenesis in the eye 
is the major cause of blindness in such conditions as retinop-
athy of prematurity, age-related macular degeneration (AMD), 
and diabetic retinopathy. AMD is the leading cause of blind-
ness in persons over the age of 55 years in developed coun-
tries [2]. Although the detailed disease mechanism is not suf-
ficiently understood as of yet, choroidal neovascularization 
(CNV) leads to severe vision loss in patients with AMD. 
CNV invades the subretinal space through choroidal vessel 
proliferation following rupture of Bruch’s membrane. 
Vascular endothelial growth factor (VEGF) has been shown 
to be a key mediator of angiogenesis and a vascular perme-
ability-enhancing factor during the development of CNV [3].
Chlorogenic acid, the ester of caffeic acid with quinic 
acid, is one of the most abundant polyphenol compounds in 
the human diet. It is a major phenolic compound in coffee, 
is widespread in plants, and can be isolated from leaves and 
fruit [4]. This compound, long known as an antioxidant [5], 
has also been reported to have anti-inflammatory properties 
[6], anticarcinogenic activities [7,8], and protective effects 
on neuronal cells [9]. Furthermore, epidemiological studies 
have highlighted the association between the consumption 
of polyphenol-rich foods and beverages and the prevention 
of type 2 diabetes mellitus and cardiovascular disease 
[10-12].
In the study presented here, we investigated the anti-
angiogenic effects of chlorogenic acid on laser-induced CNV 
in a rat model. 
Materials and Methods
Animals
Brown Norway rats weighing 200 to 250 g were purchased Korean J Ophthalmol Vol.24, No.3, 2010
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Fig. 1. Hematoxylin-eosin stainings of representative areas of choroidal neovascularization (CNV) at the sites of laser-induced trauma in the 
control group (A) and chlorogenic acid-treated group (B). Intraperitoneal injection of chlorogenic acid (10 mg/kg) was started one day prior 
to laser photocoagulation and continued for eight days. The eyes were removed 14 days after laser photocoagulation. Note the presence of la-
ser-induced CNV in each group (between white arrows). 
from Samtako (Osan, Korea). Care, use, and treatment of all 
animals in this study were in strict compliance with the   
Association for Research in Vision and Ophthalmology 
Statement for the Use of Animals in Ophthalmic and Vision 
Research. Animals were subjected to standard 12-hour 
dark-light cycles and were kept at approximately 23℃ of 
room temperature.
Laser-induced choroidal neovascularization
Brown Norway rats were anesthetized with zolazepam 
and xylazine hydrochloride and their pupils were dilated 
with topical 0.5% tropicamide (Alcon Laboratories, Inc., 
Fort Worth, TX, USA). Choroidal neovascularization was 
induced in one eye using a green argon laser (532 nm, 75 
µm diameter spot size, 200 mW, 0.1 sec). Six to nine spots 
were applied in a peripapillary distribution in a standardized 
fashion, approximately one to three disc diameters from the 
optic nerve, using a slit lamp delivery system and a cover-
slip as a contact lens. The appearance of a cavitation bubble, 
a sign thought to correlate with disruption of Bruch’s mem-
brane, was recorded for further evaluation. Spots containing 
hemorrhage or failing to develop an evident bubble at the 
laser impact site were excluded from further analysis. 
Preparation and injection of chlorogenic acid
Chlorogenic acid (Sigma-Aldrich, St Louis, MO, USA) 
was dissolved in phosphate-buffered saline (10 mg/mL). Rats 
were randomly divided into chlorogenic acid-treated and 
control groups (ten rats per group). Intraperitoneal injection 
of chlorogenic acid (10 mg/kg) was started one day prior to 
laser photocoagulation and continued for eight days. In the 
control group, normal saline was injected using the same 
schedule. 
Histological analysis and CNV size measurement
Fourteen days after laser photocoagulation, the eyes were 
removed, fixed in 4% paraformaldehyde in 0.1-M phosphate 
buffer for 24 hours, and embedded in paraffin. Sagittal sec-
tions of 4 to 5 µm, each 10 µm apart, were cut through the 
center of the laser photocoagulation site. Sections were 
stained with hematoxylin and eosin so that CNV could be as-
sessed via light microscopy (Carl Zeiss, Dublin, CA, USA). 
Images were captured using a digital camera attached to a 
Carl Zeiss microscope. We used a computer-assisted image 
analysis system (AxioVision 4AC ver. 4.3; Carl Zeiss) to es-
timate neovascularization based on the B/C ratio (the thick-
ness from the bottom of the pigmented choroidal layer to the 
top of the neovascular membrane [B] compared to the thick-
ness of the intact-pigmented choroid adjacent to the lesion 
[C]) [13]. In addition, the total CNV size was measured by 
calculating the area in the sagittal section of the CNV lesion 
using the same image analysis software. Measurements were 
performed in five sections from each laser photocoagulation 
site by two independent observers blinded to the treatments 
(CK and HGY).    
Quantitative assessment of CNV using fluorescein 
angiography
An operator masked to the treatment performed fluo-
rescein angiography with a commercial camera and imaging 
system (TRC-50DX and IMAGEnet ver. 1.53; Topcon, Tokyo, 
Japan) seven and 14 days after laser photocoagulation. 
Photographs were captured with a 20-D lens in contact with 
the fundus camera lens after intraperitoneal injection of 0.6 
mL 2% fluorescein sodium (Novartis Korea, Seoul, Korea). 
CNV lesions were graded by two masked retinal specialists 
(CK and HGY) using a previously established scheme, as C Kim, et al. Anti-angiogenic Effect of Chlorogenic Acid on CNV
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Fig. 2. (A) In order to evaluate changes in the choroidal neo-
vascularization lesion, the ratios of B (the thickness from the bottom 
of the pigmented choroidal layer to the top of the neovascular mem-
brane) to C (the thickness of the intact-pigmented choroid adjacent 
to the lesion) were compared. (B) There was no significant differ-
ence in the B/C ratio between the chlorogenic acid-treated and con-
trol groups. 
p=0.852
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Fig. 3. (A) Representative histological image for the quantification 
of  choroidal neovascularization (CNV) size in a sagittal section us-
ing a computer-assisted image analysis system. (B) No significant 
difference in the mean CNV area was observed between chloro-
genic acid-treated and control groups. 
follows: 0 (not leaky), faint hyperfluorescence or mottled 
fluorescence without leakage; 1 (questionable leakage), hy-
perfluorescent lesion without progressive increase in size or 
intensity; 2 (leaky), hyperfluorescence increasing in in-
tensity but not in size; and 3 (pathologically significant 
leakage), hyperfluorescence increasing in intensity and in 
size. In addition, the CNV area on fluorescein angiography 
was measured by calculating the areas of pixels brighter 
than the background within the CNV lesion. 
Statistical analysis
 All values are presented as the mean±SD. Differences in 
B/C ratio and CNV area between the two groups were stat-
istically compared using Student’s t-test (two-tailed), and the 
difference CNV lesion grade as determined by fluorescein 
angiography between the two groups was evaluated using 
Pearson's Chi-square test. A p＜0.05 was considered statisti-
cally significant. 
Results
Histological analysis
As demonstrated in Fig. 1, histological staining showed 
the formation of laser-induced CNV in each group. In order 
to evaluate changes in the CNV lesions, we compared the ratio 
of B (the thickness from the bottom of the pigmented choroidal 
layer to the top of the neovascular membrane) to C (the thick-
ness of the intact-pigmented choroid adjacent to the lesion). 
The mean B/C ratios were 2.89±0.85 in the control group and 
2.89±0.55 in the chlorogenic acid group, showing no sig-
nificant difference (Fig. 2). In addition, when the total CNV 
size was evaluated in the sagittal section, the mean CNV area 
were 17,951±7,658 µm
2 in the control group and 17,398± Korean J Ophthalmol Vol.24, No.3, 2010
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Fig. 4. Angiographic analysis of choroidal neovascularization (CNV) leakage sevenand 14 days after laser photocoagulation between chloro-
genic acid-treated and control groups. (A) Chlorogenic acid-treated rats developed reduced CNV and leakage at 14 days compared with those 
of control rats. (B) Histogram of angiographic leakage grades. Pathologically significant leakage (grade 3) was observed in 6.5% of CNV le-
sions in chlorogenic acid-treated rats at 14 days, while it was observedin a significantly higher proportion (61.8%) of lesions in control rats 
(p<0.001). FAG=fluorescein angiography.
5,062 µm
2 in the chlorogenic acid group. No significant dif-
ference in the mean CNV area was observed between the two 
groups (Fig. 3)
 .
Angiographic analysis of CNV leakage 
Comparison of fluorescein angiograms revealed that 
chlorogenic acid-treated rats had reduced CNV and leakage 
compared to those of control rats. At day 7, there was no sig-
nificant difference in the grade of leakage between the 
chlorogenic acid and control groups (p=0.289). However, at 
day 14, retina of chlorogenic acid-treated rats showed sig-
nificantly reduced CNV and leakage (Fig. 4). Pathologically 
significant leakage (grade 3) was observed only in 6.5% of 
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Fig. 5. Angiographic analysis of choroidal neovascularization 
(CNV) size demonstrated that the chlorogenic acid-treated group 
had a significant decrease in CNV area at day 7 and day 14 com-
pared with those of the control group. FAG=fluorescein angiography.
CNV lesions in chlorogenic acid-treated rats, while it was 
observed in a significantly higher proportion (61.8%) of le-
sions in control rats (p＜0.001). 
Angiographic analysis of CNV size 
Angiographic analysis of CNV size demonstrated that the 
chlorogenic acid-treated group had significant decrease in 
CNV area at day 7 and day 14 compared with those of the 
control group (Fig. 5). The mean CNV area in the chlorogenic 
acid-treated group was 70.6% of that in the control group at 
day 7 (p＜0.001) and 58.4% of that at day 14 (p＜0.001). 
Discussion
The impact of nutrition on the manifestation and progression 
of retinal disease has been an important and controversial 
topic in recent years [14]. Many potential beneficial nutritional 
effects on retinal diseases are still insufficiently understood. 
Chlorogenic acid is particularly abundant in coffee, but it is 
also the principal phenolic acid found in common foods such 
as sweet potatoes and apples [15,16]. Chlorogenic acid has 
been shown to have biological activities, including anti-
oxidant, anti-inflammatory, and anticarcinogenic effects. 
In this study, we sought to determine if chlorogenic acid 
had an anti-angiogenic effect on CNV in rat retina. Indeed, 
we found that chlorogenic acid significantly reduced vas-
cular leakage and CNV size on fluorescein angiography, 
whereas histological findings were not significantly different 
between the groups. The reasons for this discordance be-
tween histological and angiographic findings should be fur-
ther studied. In this study, we started injecting chlorogenic 
acid one day laser photocoagulation and continued for eight 
days. It is possible that our injection schedule of one day pre-
treatment and continuing for seven days after treatment may 
have been insufficient to confirm the histological changes of 
CNV [13,17,18]. Previous studies demonstrating the anti-
angiogenic effects of other antioxidants or inhibitors show 
longer treatment periods of at least two to six weeks. In addi-
tion, it is possible that chlorogenic acid has anti-angiogenic 
effects that could reduce the activity of preformed CNV, but 
does not affect laser-induced CNV formation itself. Therefore, 
further study with longer treatment periods of two to three 
weeks may be needed to demonstrate the histological 
changes of CNV induced by chlorogenic acid. 
Angiogenesis regulation is a complex process involving 
enzymatic and signal transduction cascades that function in 
fibrinolysis, matrix remodeling, inflammation, hemodynamic 
control of oxygenation, and growth regulation [19,20]. 
Therefore, it is important to identify the possible mechanisms 
of chlorogenic acid action on the mediators of angiogenesis. 
Chlorogenic acid has been studied for its wide-ranging effects 
on antioxidant, anti-inflammatory, and anti-carcinogenic 
activities. It is not known, however, if chlorogenic acid has 
any effects on the regulation of angiogenesis. Furthermore, 
the potential molecular mechanism involved is unknown. In 
this study, we found that chlorogenic acid had an anti-angiogenic 
effect on CNV through reductions in vascular leakage and 
CNV size. We offer some hypotheses concerning the molecular 
mechanism by which chlorogenic acid exerts its anti-angiogenic 
effects on CNV. First, matrix metalloproteinases (MMPs) 
have been suggested to be involved in the progression of both 
retinal and choroidal neovascularization [21,22]. MMP-9 
secretion from inflammatory cells has also been demonstrated 
to contribute to the development of pathological choroidal 
angiogenesis [13,23]. Furthermore, a recent study has re-
vealed that chlorogenic acid is a strong type of MMP-9 in-
hibitor, suggesting a possible mechanisms for cancer chemo-
prevention [24]. Hence, it is possible that chlorogenic acid 
has an anti-angiogenic effect on CNV by inhibiting MMP-9, 
which may play an essential role in angiogenesis. 
It is also possible that the anti-angiogenic effect of chloro-
genic acid is derived from its basic properties as an antioxidant. 
The retina is subjected to high oxidative stress, to which it is 
also highly susceptible. Oxidative stress caused by reactive 
oxygen intermediates is a well-known, significant mechanism 
contributing to the pathogenesis of AMD [25]. Although 
VEGF and other cytokines are involved in CNV, oxidative 
stress may predispose the eye to increased levels of proan-
giogenic factors, whichare likely to promote CNV [26]. 
Other studies have demonstrated superoxide-associated in-
creases in VEGF mRNA and protein [27], and tert-bu-
tyl-hydroperoxide, a pro-oxidative stressor, has been shown 
to induce VEGF mRNA and protein upregulation [28]. These 
studies may provide insight into the anti-angiogenic activity 
of chlorogenic acid, which has been shown to be a potent an-
tioxidant through its radical-scavenging activities [5,29]. 
However, further studies are required to elucidate the exact 
mechanism by which chlorogenic acid exerts its anti-
angiogenic activity on CNV.
In conclusion, we provide the first evidence that chloro-
genic acid could have an anti-angiogenic effect on CNV. We Korean J Ophthalmol Vol.24, No.3, 2010
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suggest that chlorogenic acid may provide a promising alter-
native strategy for the treatment or prevention of neovascular 
AMD. 
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